Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities
Thomas B. Casale(University of South Florida), Beth Hahn(Research Triangle Park Foundation), Michael Bogart(Research Triangle Park Foundation), Jared Silver(Research Triangle Park Foundation), Elizabeth Packnett(IBM (United States)), Néstor A. Molfino(Amgen (United States)), Donna McMorrow(IBM (United States)), Joanne Wu
Cited by 46
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k